While gout is commonly linked to excessive drinking or poor diet, new research has revealed that genetics may play a larger ...

In subsequent attacks, more joints may be affected and the attack may become more severe. In some individuals, particularly the elderly, gout episodes become chronic, and crystals of uric acid ...

and tolerability of serum uric acid lowering and maintenance with febuxostat in patients with gout. Febuxostat Open-label Clinical Trial of Urate-lowering Efficacy and Safety Adverse events were ...

Gout causes sudden flares of joint pain, which often arise during the nighttime, and in the big toe, though it may affect other joints including the ankles | Genetics And Genomics ...

This week's topics include the impact of lipoprotein(a), or Lp(a), frailty as a predictor of dementia, a diabetes medicine in kidney stones and gout, and the impact of multiple chronic medical ...

Intercritical gout. This is the time between gout flares when you have no symptoms, although uric acid levels are still high. Chronic gout. In this advanced stage of gout, hardened deposits of ...

Sudden and severe pain in the joints, particularly in the big toe, is a common sign of gout, which is caused by high uric acid levels. Swelling and Inflammation: Joints may become swollen, red, and ...

Sweden’s Sobi has kicked off a rolling biologics license application in the US for SEL-212, vying to become a new option for patients with refractory chronic gout that doesn’t respond to ...

A major international study has found gout is a chronic illness where genetics is a major cause, rather than lifestyle choices of the sufferer. Led by University of Otago researchers, the genome ...

inhibitor drugs to treat type 2 diabetes may also help to lower the risk of recurrent kidney stones and gout flare-ups, finds a study from Canada published by BMJ. Chronic kidney disease (CKD ...

DISSOLVE 1 Phase 3 study: Results of a post hoc analysis of sustained sUA reduction and safety of SEL-212 in patients with chronic refractory gout living in the United States. Results from a Phase 3 ...

Febuxostat is a second-line option for patients with gout who are unable to take allopurinol due to hypersensitivity, intolerance, or lack of efficacy in achieving a target serum uric acid ...